abstract |
A method of treating bone loss comprises co-administering therapeutically effective amounts of parathyroid hormone and a compound of the formula n n n or a pharmaceutically acceptable salt thereof wherein R 1 and R 2 are independently selected from the group consisting of hydrogen and alkyl of one to six carbon atoms. n The co-administration may take the mode of simultaneous, concurrent, or sequential administration of the two compounds. |